Bioheart Partners With Life Technologies to Offer Myoblast Cell Products to the Research Market
December 18, 2008 10:45 ET
|
Bioheart, Inc.
SUNRISE, Fla., Dec. 18, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) and Life Technologies Corporation (Nasdaq:LIFE) have entered into a global distribution and OEM agreement to sell myoblast...
Bioheart, Inc. Announces Plans to Divest Non-Core Products to Increase Focus On Heart Failure Treatments
December 16, 2008 10:45 ET
|
Bioheart, Inc.
SUNRISE, Fla., Dec. 16, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today that it is planning to spin out or sell off its interest in several non-core technology platforms in order...
Bioheart Files for Reimbursement Approval in Europe for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
December 01, 2008 12:48 ET
|
Bioheart, Inc.
SUNRISE, Fla., Dec. 1, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has filed with appropriate agencies in Italy, Germany and the Netherlands for reimbursement approval for...
Bioheart, Inc. Reports Receipt of Notice of Delisting From The NASDAQ Capital Market
November 20, 2008 14:55 ET
|
Bioheart, Inc.
SUNRISE, Fla., Nov. 20, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) (the "Company") previously disclosed, on October 15, 2008, that it received a letter from The NASDAQ Stock Market (the...
Bioheart Announces CE Marking for TGI 1200(tm) Adult Stem Cell Isolation System
November 20, 2008 08:00 ET
|
Bioheart, Inc.
SUNRISE, Fla., Nov. 20, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure...
Bioheart Receives Notice of Allowance for Nine New U.S. Patent Claims for Utilizing Electrical Stimulation to Enhance Stem Cell Regeneration of Damaged Heart Muscle
November 06, 2008 08:20 ET
|
Bioheart, Inc.
SUNRISE, Fla., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office for nine new...
Bioheart Adds Key Senior Members to Its Team: Vice President of Sales & Marketing and Seasoned Board Member
November 05, 2008 08:00 ET
|
Bioheart, Inc.
SUNRISE, Fla., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today two key appointments to its leadership team including a new vice president of sales and marketing and a new...
Bioheart to Present At the Rodman & Renshaw 10th Annual Healthcare Conference in New York City
November 04, 2008 08:15 ET
|
Bioheart, Inc.
SUNRISE, Fla., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure...
Bioheart Announces Termination of Letter of Intent to Acquire Medicalgorithmics
October 31, 2008 16:20 ET
|
Bioheart, Inc.
SUNRISE, Fla., Oct. 31, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc., (Nasdaq:BHRT), today announced that its non-binding letter of intent to acquire Medicalgorithmics SP. z.o.o. has been...
Bioheart and Monebo Announce Distribution and Licensing Agreement for Heart Monitoring Technologies
October 30, 2008 16:54 ET
|
Bioheart, Inc.
SUNRISE, Fla., Oct. 30, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) and Monebo, Inc. today announced they have signed a licensing agreement that provides Bioheart the right to distribute...